Compare FDA CSA guidance and FDA software validation

How to read this page

Details: Guide Definitions: every term and label explained

How they are linked

Side by side

FDA CSA guidanceFDA software validation
AuthorityFDAFDA
Legal weightGuidance & Q&AGuidance & Q&A
StatusFinalFinal
Last verifiedNot yetNot yet
Summary

FDA's risk-based approach to assuring software used in production and quality systems, favouring critical thinking and unscripted testing where risk is lower. Final since September 2025 and updated in February 2026 to align with the QMSR.

FDA guidance setting out the validation principles it considers applicable to medical device software, and to software used to design, develop or manufacture medical devices.

Lifecycle
  • 13 Sep 2022 Draft guidance published
  • 24 Sep 2025 Final guidance published
  • 3 Feb 2026 Updated and retitled for QMS software
  • 9 Jun 1997 Draft version 1.1 dated 9 Jun 1997
  • 11 Jan 2002 Version 2.0 issued, superseding the 1997 draft
SourceOfficial text
Source: FDA. Public domain.
Official text
Source: FDA. Public domain.

These facts are placed side by side from each record. This page does not say which is stricter or whether requirements differ. Read the official texts.